Phase I clinical trial of gemcitabine (GEM) in combination with PF-00477736 (PF-736), a selective inhibitor of CHK1 kinase Meeting Abstract

  


Authors: Brega, N.; McArthur, G. A.; Britten, C.; Wong, S. G.; Wang, E.; Wilner, K. D.; Blasina, A.; Schwartz, G. K.; Gallo, J.; Tse, A. N.
Abstract Title: Phase I clinical trial of gemcitabine (GEM) in combination with PF-00477736 (PF-736), a selective inhibitor of CHK1 kinase
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 248s
Language: English
ACCESSION: WOS:000208852003267
DOI: 10.1200/jco.2010.28.15_suppl.3062
PROVIDER: wos
Notes: Meeting Abstract: 3062 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Archie Tse
    34 Tse
Related MSK Work